Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy.

Aeran Seol,Ga Won Yim,Joo Yeon Chung,Se Ik Kim,Maria Lee,Hee Seung Kim,Hyun Hoon Chung,Jae-Weon Kim,Noh Hyun Park,Yong Sang Song

Cancer research and treatment（2022）

引用 1|浏览10

暂无评分

摘要

Third and subsequent lines of chemotherapy could be carefully considered for palliative purposes in recurrent EOC patients with serous or endometrioid histology, initial platinum sensitivity, and long TFIs from the previous chemotherapy regimen.

查看译文

关键词

Drug therapy,Epithelial ovarian carcinoma,Prognosis,Recurrence,Survival,Treatment response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要